{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:58Z","timestamp":1786980598896,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Open access funding provided by Universit\u00e0 degli Studi di Sassari within the CRUI-CARE Agreement"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Human serum paraoxonase-1 (PON-1) is a critical antioxidant defense system against lipid oxidation. Decreased PON-1 activity has been associated with systemic oxidative stress in several disease states. We conducted a systematic review and meta-analysis of plasma\/serum concentrations of PON-1 paraoxonase and arylesterase activity in psoriasis, a chronic immune-mediated and inflammatory skin disease. The electronic databases PubMed, Web of Science, and Scopus were searched from inception to November 2021. In total, 14 studies in 691 psoriatic patients and 724 healthy controls were included in the meta-analysis. Serum paraoxonase activity was significantly lower in psoriatic patients (SMD\u2009=\u2009\u2212\u20092.30, 95% CI \u2212\u20093.17 to \u2212\u20091.42;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001); however, no significant between-group differences were observed in serum arylesterase activity (SMD\u2009=\u2009\u2212\u20090.34, 95% CI \u2212\u20090.11 to 0.80;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.14). The pooled SMD values were not substantially altered in sensitivity analysis. There was no publication bias. In conclusion, our meta-analysis has shown that serum paraoxonase, but not arylesterase, activity is significantly lower in psoriasis, suggesting an impaired antioxidant defense in these patients.\n                  <\/jats:p>","DOI":"10.1007\/s10238-022-00818-z","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T01:02:34Z","timestamp":1647824554000},"page":"301-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Paraoxonase and arylesterase activity of serum PON-1 enzyme in psoriatic patients: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6230-8241","authenticated-orcid":false,"given":"Stefania","family":"Bassu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arduino A.","family":"Mangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Satta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Argiolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciriaco","family":"Carru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Zinellu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"818_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2133.1999.140S54001.x","volume":"140","author":"JP Ortonne","year":"1999","unstructured":"Ortonne JP. Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol. 1999;140:1\u20137.","journal-title":"Br J Dermatol"},{"key":"818_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000247421","volume":"185","author":"O Simonetti","year":"1992","unstructured":"Simonetti O, Ferretti G, Salvi A, Offidani AM, Bossi G. Plasma lipid changes in psoriatic children. Dermatology. 1992;185:96\u2013100.","journal-title":"Dermatology"},{"key":"818_CR3","doi-asserted-by":"publisher","first-page":"535612","DOI":"10.1155\/2010\/535612","volume":"2010","author":"A Pietrzak","year":"2010","unstructured":"Pietrzak A, Michalak-Stoma A, Chodorowska G, Szepietowski JC. Lipid disturbances in psoriasis: an update. Mediat Inflamm. 2010;2010:535612.","journal-title":"Mediat Inflamm"},{"key":"818_CR4","first-page":"78454","volume":"2007","author":"NS Tekin","year":"2007","unstructured":"Tekin NS, Tekin IO, Barut F, Sipahi EY. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients. Mediat Inflamm. 2007;2007:78454.","journal-title":"Mediat Inflamm"},{"key":"818_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jdermsci.2009.05.008","volume":"55","author":"S Coimbra","year":"2009","unstructured":"Coimbra S, Oliveira H, Reis F, et al. Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. J Dermatol Sci. 2009;55:202\u20134.","journal-title":"J Dermatol Sci"},{"key":"818_CR6","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/j.1468-3083.2011.03982.x","volume":"25","author":"S Kaur","year":"2011","unstructured":"Kaur S, Zilmer K, Leping V, Zilmer M. The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis. J Eur Acad Dermatol Venereol. 2011;25:1328\u201333.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"818_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0009-8981(02)00373-X","volume":"328","author":"BV Kural","year":"2003","unstructured":"Kural BV, Orema A, Cimsit G, Yandi YE, Calapoglu M. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant\u2013antioxidant system in patients with psoriasis. Clin Chim Acta. 2003;328:71\u201382.","journal-title":"Clin Chim Acta"},{"key":"818_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0009-8981(99)00150-3","volume":"289","author":"I Kokcam","year":"1999","unstructured":"Kokcam I, Naziroglu M. Antioxidants and lipid peroxidation status in the blood of patients with psoriasis. Clin Chim Acta. 1999;289:23\u201331.","journal-title":"Clin Chim Acta"},{"key":"818_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2009.09.025","volume":"410","author":"B Goswami","year":"2009","unstructured":"Goswami B, Tayal D, Gupta N, Mallika V. Paraoxonase: a multifaceted biomolecule. Clin Chim Acta. 2009;410:1\u201312.","journal-title":"Clin Chim Acta"},{"key":"818_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0021-9150(93)90183-U","volume":"104","author":"MI Mackness","year":"1993","unstructured":"Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 1993;104:129\u201335.","journal-title":"Atherosclerosis"},{"key":"818_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1042\/bj0530117","volume":"53","author":"WN Aldridge","year":"1953","unstructured":"Aldridge WN. Serum esterases II. An enzyme hydrolysing diethyl pnitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera. Biochem J. 1953;53:117\u201324.","journal-title":"Biochem J"},{"key":"818_CR12","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1172\/JCI118359","volume":"96","author":"AD Watson","year":"1995","unstructured":"Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Investig. 1995;96:2882\u201391.","journal-title":"J Clin Investig"},{"key":"818_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0025-7753(03)74011-1","volume":"121","author":"A Canales","year":"2003","unstructured":"Canales A, Sanchez-Muniz FJ. Paraoxonase, something more than an enzyme? Med Clin (Barc). 2003;121:537\u201348.","journal-title":"Med Clin (Barc)"},{"issue":"4","key":"818_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/MOL.0b013e32832ca1ee","volume":"20","author":"DM Shih","year":"2009","unstructured":"Shih DM, Lusis AJ. The roles of PON1 and PON2 in cardiovascular disease and innate immunity. Curr Opin Lipidol. 2009;20(4):288\u201392.","journal-title":"Curr Opin Lipidol"},{"issue":"11","key":"818_CR15","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1161\/ATVBAHA.112.253930","volume":"32","author":"WH Tang","year":"2012","unstructured":"Tang WH, Hartiala J, Fan Y, et al. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol. 2012;32(11):2803\u201312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"818_CR16","volume-title":"Joanna Briggs Institute reviewer\u2019s manual","author":"S Moola","year":"2017","unstructured":"Moola S, Munn Z, Tufanaru C, et al. Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors., et al., Joanna Briggs Institute reviewer\u2019s manual. Adelaide: Johanna Briggs Institute; 2017."},{"key":"818_CR17","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Erlbaum; 1988.","edition":"2"},{"key":"818_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","volume":"87","author":"M Hultcrantz","year":"2017","unstructured":"Hultcrantz M, Rind D, Akl EA, et al. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017;87:4\u201313.","journal-title":"J Clin Epidemiol"},{"key":"818_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jclinepi.2018.05.011","volume":"111","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Coello PA, Guyatt GH, et al. GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences-inconsistency, imprecision, and other domains. J Clin Epidemiol. 2019;111:83\u201393.","journal-title":"J Clin Epidemiol"},{"key":"818_CR20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"818_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"key":"818_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"818_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2288-11-41","volume":"11","author":"J Bowden","year":"2011","unstructured":"Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol. 2011;11:41.","journal-title":"BMC Med Res Methodol"},{"key":"818_CR24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"issue":"47","key":"818_CR25","first-page":"15","volume":"8","author":"A Tobias","year":"1999","unstructured":"Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;8(47):15\u20137.","journal-title":"Stata Tech Bull"},{"issue":"4","key":"818_CR26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101.","journal-title":"Biometrics"},{"issue":"10","key":"818_CR27","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","volume":"54","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046\u201355.","journal-title":"J Clin Epidemiol"},{"key":"818_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455\u201363.","journal-title":"Biometrics"},{"issue":"3","key":"818_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/cbf.1553","volume":"27","author":"A Toker","year":"2009","unstructured":"Toker A, Kadi M, Yildirim AK, Aksoy H, Ak\u00e7ay F. Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct. 2009;27(3):176\u201380.","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"818_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1365-2133.2011.10539.x","volume":"166","author":"G Ferretti","year":"2012","unstructured":"Ferretti G, Bacchetti T, Campanati A, Simonetti O, Liberati G, Offidani A. Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1. Br J Dermatol. 2012;166(1):204\u20137.","journal-title":"Br J Dermatol"},{"issue":"4","key":"818_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/jcla.20471","volume":"25","author":"M Usta","year":"2011","unstructured":"Usta M, Turan E, Aral H, Inal BB, Gurel MS, Guvenen G. Serum paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with\/without metabolic syndrome. J Clin Lab Anal. 2011;25(4):289\u201395.","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"818_CR32","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1365-2133.2012.11170.x","volume":"167","author":"M Asefi","year":"2012","unstructured":"Asefi M, Vaisi-Raygani A, Bahrehmand F, et al. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis. Br J Dermatol. 2012;167(6):1279\u201386.","journal-title":"Br J Dermatol"},{"issue":"3","key":"818_CR33","doi-asserted-by":"publisher","first-page":"e370","DOI":"10.1111\/j.1468-3083.2012.04700.x","volume":"27","author":"S Emre","year":"2013","unstructured":"Emre S, Metin A, Demirseren DD, Kilic S, Isikoglu S, Erel O. The relationship between oxidative stress, smoking and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol. 2013;27(3):e370\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"818_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000342124","volume":"26","author":"R Ramadan","year":"2013","unstructured":"Ramadan R, Tawdy A, Abdel Hay R, Rashed L, Tawfik D. The antioxidant role of paraoxonase 1 and vitamin E in three autoimmune diseases. Skin Pharmacol Physiol. 2013;26(1):2\u20137.","journal-title":"Skin Pharmacol Physiol"},{"issue":"12","key":"818_CR35","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.bbalip.2014.09.008","volume":"1841","author":"L He","year":"2014","unstructured":"He L, Qin S, Dang L, et al. Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein. Biochim Biophys Acta. 2014;1841(12):1709\u201315.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"818_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/jid.2013.359","volume":"134","author":"M Holzer","year":"2014","unstructured":"Holzer M, Wolf P, Inzinger M, et al. Anti-psoriatic therapy recovers high-density lipoprotein composition and function. J Investig Dermatol. 2014;134(3):635\u201342.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"818_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/cbf.3011","volume":"32","author":"H Nemati","year":"2014","unstructured":"Nemati H, Khodarahmi R, Sadeghi M, Ebrahimi A, Rezaei M, Vaisi-Raygani A. Antioxidant status in patients with psoriasis. Cell Biochem Funct. 2014;32(3):268\u201373.","journal-title":"Cell Biochem Funct"},{"issue":"8","key":"818_CR38","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/art.40499","volume":"70","author":"ME Husni","year":"2018","unstructured":"Husni ME, Wilson Tang WH, Lucke M, Chandrasekharan UM, Brennan DM, Hazen SL. Correlation of high-density lipoprotein-associated paraoxonase 1 activity with systemic inflammation, disease activity, and cardiovascular risk factors in psoriatic disease. Arthritis Rheumatol. 2018;70(8):1240\u201350.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"818_CR39","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.118.313608","volume":"123","author":"AV Sorokin","year":"2018","unstructured":"Sorokin AV, Kotani K, Elnabawi YA, et al. Association between oxidation-modified lipoproteins and coronary plaque in psoriasis. Circ Res. 2018;123(11):1244\u201354.","journal-title":"Circ Res"},{"issue":"1","key":"818_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00403-019-01976-z","volume":"312","author":"T Bacchetti","year":"2020","unstructured":"Bacchetti T, Simonetti O, Ricotti F, Offidani A, Ferretti G. Plasma oxidation status and antioxidant capacity in psoriatic children. Arch Dermatol Res. 2020;312(1):33\u20139.","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"818_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5114\/ada.2020.93386","volume":"37","author":"M Oszukowska","year":"2020","unstructured":"Oszukowska M, Koz\u0142owska M, Kaszuba A. Paraoxonase-1 and other factors related to oxidative stress in psoriasis. Postepy Dermatol Alergol. 2020;37(1):92\u20136.","journal-title":"Postepy Dermatol Alergol"},{"issue":"7","key":"818_CR42","first-page":"38","volume":"14","author":"S Shakoei","year":"2021","unstructured":"Shakoei S, Nakhjavani M, Mirmiranpoor H, Motlagh MA, Azizpour A, Abedini R. The serum level of oxidative stress and antioxidant markers in patients with psoriasis: a cross-sectional study. Clin Aesthet Dermatol. 2021;14(7):38\u201341.","journal-title":"Clin Aesthet Dermatol"},{"issue":"8","key":"818_CR43","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3390\/antiox9080683","volume":"9","author":"V Rosta","year":"2020","unstructured":"Rosta V, Trentini A, Passaro A, et al. Sex difference impacts on the relationship between Paraoxonase-1 (PON1) and type 2 diabetes. Antioxidants (Basel). 2020;9(8):683.","journal-title":"Antioxidants (Basel)"},{"key":"818_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","volume":"567","author":"M Mackness","year":"2015","unstructured":"Mackness M, Mackness B. Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles. Gene. 2015;567:12\u201321.","journal-title":"Gene"},{"key":"818_CR45","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/bjd.12144","volume":"168","author":"T Bacchetti","year":"2013","unstructured":"Bacchetti T, Campanati A, Ferreti G, Simonetti O, Liberati G, Offidani AM. Oxidative stress and psoriasis: the effect of antitumour necrosis factor-alpha inhibitor treatment. Br J Dermatol. 2013;168:984\u20139.","journal-title":"Br J Dermatol"},{"key":"818_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1179\/1351000213Y.0000000061","volume":"18","author":"SD Pektas","year":"2013","unstructured":"Pektas SD, Akoglu G, Metin A, Neselioglu S, Erel O. Evaluation of systemic oxidant\/antioxidant status and paraoxonase 1 enzyme activities in psoriatic patients treated by narrow band ultraviolet B phototherapy. Red Rep. 2013;18:200\u20134.","journal-title":"Red Rep"},{"key":"818_CR47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00403-013-1366-1","volume":"305","author":"S Kilic","year":"2013","unstructured":"Kilic S, Emre S, Metin A, Isikoglu S, Erel O. Effect of the systemic use of methotrexate on the oxidative stress and paraoksonase enzyme in psoriasis patients. Arch Dermatol Res. 2013;305:495\u2013500.","journal-title":"Arch Dermatol Res"},{"key":"818_CR48","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1365-2133.2012.11170.x","volume":"167","author":"M Asefi","year":"2012","unstructured":"Asefi M, Vaisi-Raygani A, Bahrehmand F, et al. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis. Br J Dermatol. 2012;167:1279\u201386.","journal-title":"Br J Dermatol"},{"key":"818_CR49","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","volume":"299","author":"T Bhattacharyya","year":"2008","unstructured":"Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA J Am Med Assoc. 2008;299:1265\u201376.","journal-title":"JAMA J Am Med Assoc"},{"key":"818_CR50","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/art.39609","volume":"68","author":"J Rodr\u00edguez-Carrio","year":"2016","unstructured":"Rodr\u00edguez-Carrio J, L\u00f3pez-Mej\u00edas R, Alperi-L\u00f3pez M, L\u00f3pez P, Ballina-Garc\u00eda FJ, Gonz\u00e1lez-Gay M\u00c1, et al. Paraoxonase 1 activity is modulated by the rs662 polymorphism and IgG anti-high-density lipoprotein antibodies in patients with rheumatoid arthritis: potential implications for cardiovascular disease. Arthritis Rheumatol. 2016;68:1367\u201376.","journal-title":"Arthritis Rheumatol"},{"key":"818_CR51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.pjnns.2016.07.002","volume":"50","author":"A Arslan","year":"2016","unstructured":"Arslan A, T\u00fcz\u00fcn FA, Arslan H, Demir H, Tamer S, Demir C, et al. The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer\u2019s patients. Neurol Neurochir Pol. 2016;50:403\u20139.","journal-title":"Neurol Neurochir Pol"},{"key":"818_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12944-021-01508-7","volume":"20","author":"C Meisinger","year":"2021","unstructured":"Meisinger C, Freuer D, Bub A, Linseisen J. Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study. Lipids Health Dis. 2021;20:81.","journal-title":"Lipids Health Dis"},{"key":"818_CR53","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.autrev.2010.12.006","volume":"10","author":"R Scrivo","year":"2011","unstructured":"Scrivo R, Vasile M, Bartosiewicz I, Valesini G. Inflammation as \u201ccommon soil\u201d of the multifactorial diseases. Autoimmun Rev. 2011;10:369\u201374.","journal-title":"Autoimmun Rev"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00818-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00818-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00818-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T12:07:49Z","timestamp":1685189269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00818-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00818-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"assertion":[{"value":"17 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}